Parise ER - Search Results

1

[13C-methacetin breath test in chronic hepatitis C liver disease].

Oliveira AC, Reber M, Lanzoni V, Ferraz ML, Parise ER. Oliveira AC, et al. Among authors: parise er. Arq Gastroenterol. 2006 Jan-Mar;43(1):41-4. doi: 10.1590/s0004-28032006000100011. Epub 2006 May 8. Arq Gastroenterol. 2006. PMID: 16699617 Free article. Portuguese.

2

Controlled production of cirrhosis in the rat liver.

Rosa H, Parise ER, Paranhos FR, Braga AL, Freitas AS, Hidalgo AN, Mor MB. Rosa H, et al. Among authors: parise er. Arq Gastroenterol. 1991 Jan-Mar;28(1):39-43. Arq Gastroenterol. 1991. PMID: 1843088

3

[Alphafetoprotein in hepatic tumours and benign liver diseases].

Forones NM, Queiroz LA, Ferraz ML, Parise ER. Forones NM, et al. Among authors: parise er. Rev Assoc Med Bras (1992). 1995 Mar-Apr;41(2):91-3. Rev Assoc Med Bras (1992). 1995. PMID: 8520603 Clinical Trial. Portuguese.

4

[Ribavirin in the treatment of hepatic cirrhosis due to hepatitis C virus. A non-controlled study].

Parise ER, Blum VF, Parisi FH. Parise ER, et al. Arq Gastroenterol. 1995 Jul-Sep;32(3):105-9. Arq Gastroenterol. 1995. PMID: 8728784 Clinical Trial. Portuguese.

5

[Serum concentration of bile acids in the diagnosis of chronic liver disease and in the functional staging].

de Almeida JM, Leite-Mór MM, Parise ER. de Almeida JM, et al. Among authors: parise er. Arq Gastroenterol. 1998 Apr-Jun;35(2):81-8. Arq Gastroenterol. 1998. PMID: 9814371 Portuguese.

6

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid.

Santos VN, Lanzoni VP, Szejnfeld J, Shigueoka D, Parise ER. Santos VN, et al. Among authors: parise er. Braz J Med Biol Res. 2003 Jun;36(6):723-9. doi: 10.1590/s0100-879x2003000600007. Epub 2003 Jun 3. Braz J Med Biol Res. 2003. PMID: 12792701 Free article. Clinical Trial.

7

[Increased serum levels of laminin in the experimental cirrhosis induced by carbon tetrachloride].

Neves LB, Catarino RM, Silva MR, Parise ER. Neves LB, et al. Among authors: parise er. Arq Gastroenterol. 2003 Jul-Sep;40(3):173-6. doi: 10.1590/s0004-28032003000300007. Epub 2004 Mar 15. Arq Gastroenterol. 2003. PMID: 15029393 Free article. Portuguese.

8

Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.

Catarino RM, Lopes JD, Forones NM, Parise ER. Catarino RM, et al. Among authors: parise er. Braz J Med Biol Res. 2005 Feb;38(2):271-6. doi: 10.1590/s0100-879x2005000200016. Epub 2005 Feb 15. Braz J Med Biol Res. 2005. PMID: 15785839 Free article.

9

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease.

Santos VN, Leite-Mór MM, Kondo M, Martins JR, Nader H, Lanzoni VP, Parise ER. Santos VN, et al. Among authors: parise er. Braz J Med Biol Res. 2005 May;38(5):747-53. doi: 10.1590/s0100-879x2005000500012. Epub 2005 May 25. Braz J Med Biol Res. 2005. PMID: 15917956 Free article.

10

Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis.

Parise ER, de Oliveira AC, Conceição RD, Amaral AC, Leite K. Parise ER, et al. Braz J Infect Dis. 2006 Apr;10(2):78-81. doi: 10.1590/s1413-86702006000200002. Braz J Infect Dis. 2006. PMID: 16878256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters